Fig. 3From: CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis opticaStatins upregulate astrocyte CD55. a CD55 and CD59 immunofluorescence in U-251MG cells after 24-h treatment with statins at 20 μM. PI-PLC control provided to show background fluorescence. b Summary of relative fluorescence as a measure of CD55 and CD59 cell surface expression, normalized to unity in the absence of statins (mean ± SEM, n = 7, **P < 0.01, unpaired Student’s t test, compared with DMSO vehicle)Back to article page